AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFALEXINE
28 registrations across 5 African markets— 20 active
Markets with CEFALEXINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OREX 500MG GELULE BOITE DE 12 | 🇨🇮Côte d'Ivoire | SOTHEMA | expired | Dec 2024 |
| OREX 250MG/5 ML GRANULE POUR SUSPENSION BUVABLE FLACON DE 60ML | 🇨🇮Côte d'Ivoire | SOTHEMA | expired | Dec 2024 |
| OREX 125MG/5 ML GRANULE POUR SUSPENSION BUVABLE FLACON DE 60ML | 🇨🇮Côte d'Ivoire | SOTHEMA | expired | Dec 2024 |
| SANCEPH-DS 250MG/ 5 ML POUDRE POUR SUSPENSION BUVABLE FLACON DE 100ML | 🇨🇮Côte d'Ivoire | SANCE LABORATORIES PVT. LTD | expired | Dec 2023 |
| KEFORAL Gélule / 500 MG | 🇹🇳Tunisia | SAIPH | expired | Oct 1997 |
| KEFORAL. Poudre pour suspension orale / 250 MG | 🇹🇳Tunisia | SAIPH | expired | Aug 1997 |
| CEFRIN Poudre pour suspension orale / 125 MG/5ML | 🇹🇳Tunisia | JULPHAR | expired | May 1992 |
| CEFRIN Poudre pour suspension orale / 250 MG | 🇹🇳Tunisia | JULPHAR | expired | May 1992 |
| AUROCEF 500 mg / B/10 | 🇸🇳Senegal | AUROBINDO PHARMA LTD | active | — |
| CEPHADEX-500 GELU BTE (1x10) CIPLA HOUSE gélule - Boite de 1x10 | 🇲🇬Madagascar | CIPLA LTD. | active | — |
| OREX suspension buvable / 250 mg / 5 ml | 🇸🇳Senegal | SOTHEMA | active | — |
| OREX GRANULE POUR SUSPENSION BUVABLE | 🇲🇦Morocco | — | active | — |
| OREX gélule / 500 mg | 🇸🇳Senegal | SOTHEMA | active | — |
| CEPHADEX 125MG/5ML PPSB BTE FL(30ML) CIPLA HOUSE poudre pour suspension | 🇲🇬Madagascar | CIPLA LTD. | active | — |
| CEFAMOR gélule / 500 mg | 🇸🇳Senegal | CADILA PHARMACEUTICALS LIMITED | active | — |
| CEPHADEX-500 GELU BTE (1x10) CIPLA HOUSE gélule - Boite de 1x10 | 🇲🇬Madagascar | CIPLA LTD. | active | — |
| CEFACURE gélule / 500 mg | 🇸🇳Senegal | ORCHID HEALTH CARE | active | — |
| CEFOVIT FORTE gélule / 500 mg | 🇸🇳Senegal | VIVENZA INTERNATIONAL | active | — |
| OREX suspension buvable / 250 mg / 5 ml | 🇸🇳Senegal | SOTHEMA | active | — |
| CEFAMOR 125MG SOLUTION INJECTABLE FLACON DE 100ML | 🇨🇮Côte d'Ivoire | CADILA PHARMACEUTICALS LIMITED | active | — |
| OREX suspension buvable / 125 mg / 5 ml | 🇸🇳Senegal | SOTHEMA | active | — |
| OREX GRANULE POUR SUSPENSION BUVABLE | 🇲🇦Morocco | — | active | — |
| CEFOVIT FORTE suspension buvable / 250 mg / 5 ml | 🇸🇳Senegal | VIVENZA INTERNATIONAL | active | — |
| CEFAMOR suspension buvable / 125 mg / 5 ml | 🇸🇳Senegal | CADILA PHARMACEUTICALS LIMITED | active | — |
| AUROCEF 250 mg / B/10 | 🇸🇳Senegal | AUROBINDO PHARMA LTD | active | — |
| CEPHADEX 125MG/5ML PPSB BTE FL(30ML) CIPLA HOUSE poudre pour suspension | 🇲🇬Madagascar | CIPLA LTD. | active | — |
| OREX GELULE | 🇲🇦Morocco | — | active | — |
| DAWACEF gélule / 500 mg | 🇸🇳Senegal | DAWA LTD | active | — |
CEFALEXINE in Africa — Regulatory Overview
CEFALEXINE is registered across 5 African markets with 28 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Madagascar, Tunisia and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 28 registrations, 20 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.